Proteomics International Laboratories Ltd.ASX: PIQ

National Rollout of PromarkerD and PromarkerEso

· Issued by Proteomics International Laboratories Ltd. via ASX

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Proteomics International Laboratories Ltd. has announced the national rollout of Promarker D and Promarker Eso blood tests, set to begin soon. This rollout is in collaboration with Healius Limited and follows a controlled market release in specific regions. Field sales teams have completed training, and systems are being integrated to facilitate patient blood collection and payment. The company is also preparing for the commercial release of Promarker Endo, expected in the near future.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX Release 23 October 2026 ASX code: PIQ National rollout of Promarker®D and Promarker®Eso to commence on 26 October 2026 Highlights • National rollout of Promarker D and Promarker Eso through Healius, Proteomics International’s exclusive Australian pathology distribution partner, scheduled...

Proteomics International Laboratories Ltd. on 6ix

Story so far

Earlier from Proteomics International Laboratories

Later from Proteomics International Laboratories

All Proteomics International Laboratories news releases